Published in Gut on January 01, 1992
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20
Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut (1996) 2.63
Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun (1995) 1.88
Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut (1996) 1.73
Role of interleukin-1 in the pathogenesis of experimental shigellosis. J Clin Invest (1995) 1.67
Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.50
Biological significance of soluble IL-2 receptor. Mediators Inflamm (1993) 1.33
Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers. J Clin Microbiol (2002) 1.19
Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis. Gut (2000) 1.17
Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig Dis Sci (1997) 1.14
Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut (1994) 1.11
Polarised interleukin 8 secretion by HT 29/19A cells. Gut (1994) 1.08
Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut (1996) 1.08
Intestinal permeability. Gut (1994) 1.05
Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med (1997) 1.04
IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. PLoS Pathog (2013) 0.96
Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Exp Immunol (1995) 0.95
Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. ACS Chem Biol (2013) 0.95
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol (2001) 0.93
Molecular mechanism of interleukin-2-induced mucosal homeostasis. Am J Physiol Cell Physiol (2011) 0.92
A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann Rheum Dis (1996) 0.91
T cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel disease. Clin Exp Immunol (1994) 0.87
Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol (2000) 0.84
Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. Int J Colorectal Dis (2005) 0.84
Murine monoclonal anti-tNF antibody administration has a beneficial effect on inflammatory bowel disease that develops in IL-10 knockout mice. Dig Dis Sci (2002) 0.82
Nucleoside-nucleotide free diet protects rat colonic mucosa from damage induced by trinitrobenzene sulphonic acid. Gut (1996) 0.82
Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder. J Neuroinflammation (2013) 0.80
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis? Gut (1995) 0.79
Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis. Gut (1993) 0.77
Soluble interleukin-2 receptors in ulcerative colitis. Mediators Inflamm (1993) 0.77
The British Society of Gastroenterology Diamond Jubilee. March 1997. Gut (1997) 0.75
Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis. Auto Immun Highlights (2013) 0.75
The role of cytokines in inflammatory bowel disease. Mediators Inflamm (1994) 0.75
Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy? Gut (1994) 0.75
Role of serotonin on the intestinal mucosal immune response to stress-induced diarrhea in weaning mice. BMC Gastroenterol (2017) 0.75
Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist. Dig Dis Sci (2003) 0.75
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
The interleukin-2 T-cell system: a new cell growth model. Science (1984) 5.81
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol (1985) 5.70
Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J Exp Med (1987) 4.53
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology (1984) 4.09
Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology (1982) 3.28
Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease. Gut (1990) 3.18
Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (1986) 2.83
A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med (1989) 2.71
High-affinity receptor-mediated internalization and degradation of interleukin 2 in human T cells. J Exp Med (1986) 2.37
Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut (1986) 2.17
Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet (1990) 2.13
The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol (1986) 2.08
Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.81
A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol (1970) 1.79
Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett (1988) 1.74
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology (1990) 1.42
Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut (1990) 1.14
Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut (1990) 1.06
Interleukin-1 affects the function of cultured human thyroid cells. Allergy (1988) 0.82
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther (2010) 2.47
Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet (1995) 1.58
Cyclosporin for polymyositis. Lancet (1984) 1.55
Treatment of refractory ulcerative colitis with cyclosporin enemas. Lancet (1989) 1.49
Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels. J Intern Med (2011) 1.46
Low-dose cyclosporin for Crohn's disease: implications for clinical trials. Aliment Pharmacol Ther (1989) 1.42
[Prevention of duodenal ulcer recurrence with penicillin]. Ugeskr Laeger (1994) 1.39
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38
Normal levels of gliadin antibodies in symptomless celiac disease. Dig Dis Sci (1988) 1.38
A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis (2000) 1.32
Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis (2007) 1.21
Validity of histopathological grading of articular cartilage from osteoarthritic knee joints. Ann Rheum Dis (1999) 1.16
Bradycardia after high-dose intravenous methylprednisolone therapy. Scand J Rheumatol (1986) 1.13
Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J Appl Physiol (1985) (1991) 1.11
Histologic/histochemical grading system for osteoarthritic articular cartilage: reproducibility and validity. Arthritis Rheum (1997) 1.06
Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut (1990) 1.06
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. Ann Rheum Dis (2008) 1.05
Effect of physical exercise on in vitro production of interleukin 1, interleukin 6, tumour necrosis factor-alpha, interleukin 2 and interferon-gamma. Int J Sports Med (1991) 1.02
Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. BMJ (1990) 0.99
Cloning and characterization of the cyclic guanosine monophosphate-inhibited phosphodiesterase PDE3A expressed in mouse oocyte. Biol Reprod (2001) 0.97
Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy. Clin Genet (2011) 0.97
The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. Scand J Gastroenterol (1997) 0.97
Dynamic autoregulation and renal injury in Dahl rats. Hypertension (1997) 0.96
Natural killer cell activity in peripheral blood of highly trained and untrained persons. Int J Sports Med (1989) 0.95
Anti-pancreatic, cellular hypersensitivity in diabetes mellitus. Experimental induction of anti-pancreatic, cellular hypersensitivity and associated morphological B-cell changes in the rat. Acta Allergol (1973) 0.95
Occupational capacity after hip replacement. Acta Orthop Scand (1985) 0.94
Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases. Infect Immun (1988) 0.94
A classification of human urothelial cells propagated in vitro. Anticancer Res (1985) 0.94
Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol (1991) 0.93
Role of cyclic nucleotide phosphodiesterases in resumption of meiosis. Mol Cell Endocrinol (1998) 0.93
Transgenic mouse models of rheumatoid arthritis. Immunol Rev (1999) 0.91
Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85 alpha regulatory subunit (codon 326 Met-->Ile) in Japanese NIDDM patients. Diabetes Care (1997) 0.91
Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. J Mol Cell Cardiol (1998) 0.90
The etiology of hypertension in nonrenovascular unilateral renal disease--two cases of renin induced hypertension in congenital renal dysplasia. Blood Press (1995) 0.90
Modulation of natural killer cell activity in peripheral blood by physical exercise. Scand J Immunol (1988) 0.90
Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation? Eur J Cardiothorac Surg (1998) 0.90
Expression of alpha and beta subunits of the integrin superfamily in articular cartilage from macroscopically normal and osteoarthritic human femoral heads. Ann Rheum Dis (1998) 0.88
CEA and carbohydrate antigens in normal and neoplastic colon mucosa. An immunohistochemical study. Acta Pathol Microbiol Immunol Scand A (1987) 0.88
Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptors. APMIS (1991) 0.88
Airway epithelium of transplanted lungs with and without direct bronchial artery revascularization. Eur J Cardiothorac Surg (1999) 0.86
Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat. Clin Exp Immunol (1992) 0.86
5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa. Scand J Gastroenterol (1987) 0.86
Modified cytokeratins expressed on the surface of carcinoma cells undergo endocytosis upon binding of human monoclonal antibody and its recombinant Fab fragment. Proc Natl Acad Sci U S A (1997) 0.86
On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scand J Gastroenterol (2002) 0.86
[Soccer injuries. II. The socioeconomic importance of injuries treated outside hospitals]. Ugeskr Laeger (1979) 0.86
Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis. J Heart Lung Transplant (2000) 0.84
Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Int J Cancer (1980) 0.84
Medium-term patency and anatomic changes after direct bronchial artery revascularization in lung and heart-lung transplantation with the internal thoracic artery conduit. J Thorac Cardiovasc Surg (1997) 0.84
Indomethacin in vitro and in vivo abolishes post-exercise suppression of natural killer cell activity in peripheral blood. Int J Sports Med (1990) 0.83
CD44 expression is up-regulated in the deep zone of osteoarthritic cartilage from human femoral heads. Histopathology (1997) 0.83
The porcine bronchial artery: surgical and angiographic anatomy. J Anat (1999) 0.83
[Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo]. Ugeskr Laeger (1988) 0.82
Comparative studies of normal, 'spontaneously' transformed and malignant human urothelium cells in vitro. Eur J Cancer Clin Oncol (1983) 0.82
Macrophage and lymphocyte chimerism in bronchoalveolar lavage cells from human lung allograft recipients. APMIS (2001) 0.81
Renal cell apoptosis in human lupus nephritis: a histological study. Lupus (2009) 0.81
Immunological characterization of cell lines establishing from malignant and normal human urothelium. Eur J Cancer (1981) 0.80
Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.80
Supposed coeliac disease during childhood and its presentation 14-38 years later. Scand J Gastroenterol (1988) 0.80
Morphological, stereological, and biochemical analysis of the mini-pig urinary bladder after chronic outflow obstruction and after recovery from obstruction. Neurourol Urodyn (1995) 0.80
Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med (1999) 0.80
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol (2000) 0.80
Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation. Transplant Proc (2011) 0.80
The treatment of presumed non-infective uveitis with cyclosporin A. Acta Ophthalmol Suppl (1985) 0.79
Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer. Br J Cancer (1998) 0.79
Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Aliment Pharmacol Ther (1992) 0.79
Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation. Genes Immun (2011) 0.79
Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur Respir J (2005) 0.79
The porcine bronchial artery. Anastomoses with oesophageal, coronary and intercostal arteries. J Anat (1999) 0.79
Adult rhabdomyoma of the oropharynx recurring three times within thirty-five years. Acta Pathol Microbiol Immunol Scand A (1986) 0.79
Effects of L-arginine on vascular smooth muscle cell proliferation and apoptosis after balloon injury. Scand Cardiovasc J (2000) 0.78
Levels of complement receptor type one (CR1, CD35) on erythrocytes, circulating immune complexes and complement C3 split products C3d and C3c are not changed by short-term physical exercise or training. Int J Sports Med (1992) 0.78
Bronchial transsection and reanastomosis in pigs with and without bronchial arterial circulation. Ann Thorac Surg (2001) 0.78
Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptor. Scand J Rheumatol (1991) 0.77
Role of protein kinase C during interferon-gamma- and phorbol ester-stimulated immunocytochemical expression of ICAM-1 in human renal carcinoma cells. APMIS (1993) 0.77
Soluble interleukin-2 receptors in serum from patients with primary Sjögren's syndrome. Scand J Rheumatol (1991) 0.77
Calcium channel blockers in kidney transplantation. Clin Transplant (1994) 0.77
Cardiac sarcoidosis and heart transplantation: a report of four consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.77
Metabolism of the aminoterminal propeptide of type III procollagen in cultures of human proximal tubular cells. Scand J Clin Lab Invest (1992) 0.77
Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant (1994) 0.77
Transitional cell carcinoma express vitamin D receptors. Scand J Urol Nephrol (1997) 0.77
ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries. Cardiovasc Res (2000) 0.76
Apoptosis in acute pulmonary allograft rejection and cytomegalovirus infection. APMIS (1999) 0.76
Comparison of the effects of tumour necrosis factor alpha stimulation and phorbol ester treatment on the immunocytochemical staining of intercellular adhesion molecule 1 in human renal carcinoma cell cultures. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.76
Cytokine production ex vivo: effect of raised body temperature. Int J Hyperthermia (1995) 0.75
Growth in children with partially treated coeliac disease. Acta Paediatr Scand (1989) 0.75
Acyclovir in the prevention of duodenal ulcer recurrence. Gut (1990) 0.75
Interferon-gamma increases cellular calcium ion concentration and inositol 1,4,5-trisphosphate formation in human renal carcinoma cells: relation to ICAM-1 antigen expression. Br J Cancer (1994) 0.75
Polymerase chain reaction as a rapid diagnostic assay for cytomegalovirus infection in renal transplant patients. APMIS (1994) 0.75
Expression of the intercellular adhesion molecule-3 (ICAM-3) in human renal tissue with relation to kidney transplants and various inflammatory diseases. APMIS (1995) 0.75
Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay. Cancer Immunol Immunother (1983) 0.75
Macrophages overloaded with tissue debris in Wegener's granulomatosis. Ann Rheum Dis (2005) 0.75
Lymphocyte-dose response relationship in spontaneous lymphocyte mediated cytotoxicity (SLMC) measured by microcytotoxicity assay. Acta Pathol Microbiol Immunol Scand C (1982) 0.75
Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium. Dan Med Bull (1985) 0.75
Role of intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1) in peripheral blood mononuclear cell activation by human renal carcinoma cells. Urol Res (1994) 0.75
[Aneurysmal bone cysts]. Ugeskr Laeger (1984) 0.75